SCHEMBL7106210

SCHEMBL7106210

O=C(O)c1ccc(Nc2nc(Nc3cccc([N+](=O)[O-])c3)nc3[nH]cnc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.53
GSK3A P49840 2/20 0.53
AURKA O14965 1/20 0.53
PIN1 Q13526 6/20 0.52
GAA P10253 1/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
MAPT P10636 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
CSNK2A1 P68400 2/20 0.48
ABCG2 Q9UNQ0 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KCNH2 Q12809 1/20 0.44
POLB P06746 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
BRD4 O60885 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7106217 1.00 GSK3B (0.53) GSK3BGSK3AAURKAPIN1GAA
SCHEMBL4901287 0.87 RAB9A (0.50) MEN1KMT2AMAPTABCG2NPC1
SCHEMBL7108322 0.85 GSK3B (0.50) GSK3BGSK3AAURKAPIN1MEN1
SCHEMBL29739789 0.85 CSNK2A1 (0.52) GSK3BGSK3AGAAMEN1KMT2A
SCHEMBL28765795 0.85 CSNK2A1 (0.52) GSK3BGSK3AGAAMEN1KMT2A
SCHEMBL7104854 0.79 SMN1; SMN2 (0.56) MEN1KMT2AMAPTCSNK2A1NPC1
SCHEMBL4489618 0.78 SRC (0.48) GAAMEN1KMT2AMAPTABCG2
SCHEMBL28765780 0.77 MAPT (0.49) MEN1KMT2AMAPTCSNK2A1ABCG2
SCHEMBL7112335 0.77 GSK3B (0.46) GSK3BGSK3AAURKAPIN1MEN1
SCHEMBL459413 0.75 IGF1R (0.51) GSK3BGSK3AAURKAGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed